Famygen Life Science

Famygen Life Sciences is an Indian biopharmaceutical company established by the Taparia family, the founders of the prominent contraceptive manufacturer Famy Care. The company focuses on the development and commercialization of complex generics, specialty pharmaceuticals, and biosimilars, with a primary emphasis on women's health, oncology, ophthalmology, and rheumatology. Through strategic collaborations, most notably with Enzene Biosciences, Famygen is advancing a pipeline of high-value biologics, including biosimilars for ranibizumab and denosumab. The company leverages its founders' extensive experience in global regulatory markets to target both emerging and developed economies with affordable, high-quality therapeutic alternatives.